Rationale and Design of the St. Francis Heart Study

1988 Wald, 1992, Cholesterol and coronary heart disease, 358 Stampfer, 1992, A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA, 268, 877, 10.1001/jama.1992.03490070059042 Haffner, 1998, The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease, Endocr Rev, 19, 583, 10.1210/er.19.5.583 Tominaga, 1999, Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study, Diabetes Care, 22, 920, 10.2337/diacare.22.6.920 Laakso, 1999, Hyperglycemia and cardiovascular disease in type 2 diabetes, Diabetes, 48, 937, 10.2337/diabetes.48.5.937 Hasdai, 1997, Outcome > or = 10 years after successful percutaneous transluminal coronary angioplasty, Am J Cardiol, 79, 1005, 10.1016/S0002-9149(97)00038-6 Rumberger, 1994, Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy, Am J Cardiol, 73, 1169, 10.1016/0002-9149(94)90176-7 Rumberger, 1995, Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study, Circulation, 92, 2157, 10.1161/01.CIR.92.8.2157 Guerci, 1997, Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults, Am J Cardiol, 79, 128, 10.1016/S0002-9149(96)00698-4 Budoff, 1996, Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease, Circulation, 93, 898, 10.1161/01.CIR.93.5.898 Schmermund, 1996, Non-invasive visualization of coronary arteries with and without calcification by electron beam computed tomography, Herz, 21, 118 Sangiorgi, 1998, Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans, J Am Coll Cardiol, 31, 126, 10.1016/S0735-1097(97)00443-9 Guerci, 1998, Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease, J Am Coll Cardiol, 32, 673, 10.1016/S0735-1097(98)00299-X Schmermund, 1999, Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease, J Am Coll Cardiol, 34, 777, 10.1016/S0735-1097(99)00265-X Arad, 1996, Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects, Circulation, 93, 1951, 10.1161/01.CIR.93.11.1951 Detrano, 1996, Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography, J Am Coll Cardiol, 27, 285, 10.1016/0735-1097(95)00460-2 Callister, 1998, Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography, N Engl J Med, 339, 1972, 10.1056/NEJM199812313392703 Brown, 1993, Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease, Circulation, 87, 1781, 10.1161/01.CIR.87.6.1781 Gotto, 1995, Lipid risk factors and the regression of atherosclerosis, Am J Cardiol, 76, 3A, 10.1016/S0002-9149(05)80009-8 Gould, 1998, New concepts and paradigms in cardiovascular medicine, Am J Med, 104, 2S, 10.1016/S0002-9343(98)00140-5 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group, N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001 Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels, JAMA, 279, 1615, 10.1001/jama.279.20.1615 Weber, 1999, Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions, Clin Chem Lab Med, 37, 243, 10.1515/CCLM.1999.043 Klouche, 1999, Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers, Arterioscler Thromb Vasc Biol, 19, 784, 10.1161/01.ATV.19.3.784 Smalley, 1996, Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1, Arterioscler Thromb Vasc Biol, 16, 585, 10.1161/01.ATV.16.4.585 Liu, 1998, Oxidized LDL damages endothelial cell monolayer and promotes thrombocyte adhesion, Am J Hematol, 57, 341, 10.1002/(SICI)1096-8652(199804)57:4<341::AID-AJH13>3.0.CO;2-B Allison, 1999, Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells, Arterioscler Thromb Vasc Biol, 19, 1354, 10.1161/01.ATV.19.5.1354 Vaisanen, 1997, Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity, Thromb Haemost, 78, 1495, 10.1055/s-0038-1665440 Ritchie, 1995, Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL, Thromb Haemost, 74, 1521, 10.1055/s-0038-1649976 Feron, 1999, Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase, J Clin Invest, 103, 897, 10.1172/JCI4829 Vogel, 1998, Cholesterol, cholesterol lowering, and endothelial function, Prog Cardiovasc Dis, 41, 117, 10.1016/S0033-0620(98)80008-X Selwyn, 1997, Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease, Circulation, 95, 5, 10.1161/01.CIR.95.1.5 Libby, 1998, Current concepts in cardiovascular pathology, Am J Med, 104, 14S, 10.1016/S0002-9343(98)00041-2 Etxabe, 1994, Morbidity and mortality in Cushing's disease, Clin Endocrinol, 40, 479, 10.1111/j.1365-2265.1994.tb02486.x Colao, 1999, Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure, J Clin Endocrinol Metab, 84, 2664, 10.1210/jc.84.8.2664 Weber, 2000, Increased diurnal plasma concentrations of cortisone in depressed patients, J Clin Endocrinol Metab, 85, 1133, 10.1210/jc.85.3.1133 Rosmond, 1998, Endocrine and metabolic aberrations in men with abdominal obesity in relation to anxio-depressive infirmity, Metabolism, 47, 1187, 10.1016/S0026-0495(98)90321-3 Keltikangas-Jarvinen, 1998, Relationships between the pituitary-adrenal hormones, insulin, and glucose in middle-aged men, Metabolism, 47, 1440, 10.1016/S0026-0495(98)90067-1 Rosmond, 1998, The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men, Int J Obes Relat Metab Disord, 22, 1184, 10.1038/sj.ijo.0800745 Keltikangas-Jarvinen, 1996, Vital exhaustion, anger expression, and pituitary and adrenocortical hormones. Implications for the insulin resistance syndrome, Arterioscler Thromb Vasc Biol, 16, 275, 10.1161/01.ATV.16.2.275 Gennarelli, 1999, Response of the pituitary-adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome, J Clin Endocrinol Metab, 84, 76, 10.1210/jc.84.1.76 Marin, 1992, Cortisol secretion in relation to body fat distribution in obese premenopausal women, Metabolism, 41, 882, 10.1016/0026-0495(92)90171-6 Barrett-Connor, 1986, A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease, N Engl J Med, 315, 1519, 10.1056/NEJM198612113152405 Barrett-Connor, 1995, Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study, Circulation, 91, 1757, 10.1161/01.CIR.91.6.1757 Arad, 1989, Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit, Arteriosclerosis, 9, 159, 10.1161/01.ATV.9.2.159 Gordon, 1990, Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer, Cancer Res, 50, 3859 Wu, 1998, Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza, Arterioscler Thromb Vasc Biol, 18, 481, 10.1161/01.ATV.18.3.481 Chang, 1995, Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation, Arterioscler Thromb Vasc Biol, 15, 1631, 10.1161/01.ATV.15.10.1631 Chen, 1997, Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine, J Am Coll Cardiol, 30, 569, 10.1016/S0735-1097(97)00158-7 Crawford, 1998, Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse, Arterioscler Thromb Vasc Biol, 18, 1506, 10.1161/01.ATV.18.9.1506 Shaish, 1999, Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model, Arterioscler Thromb Vasc Biol, 19, 1470, 10.1161/01.ATV.19.6.1470 Munday, 1998, Dietary antioxidants do not reduce fatty streak formation in the C57BL/6 mouse atherosclerosis model, Arterioscler Thromb Vasc Biol, 18, 114, 10.1161/01.ATV.18.1.114 Steinbrecher, 1997, Dietary antioxidants and cardioprotection—Fact or fallacy?, Can J Physiol Pharmacol, 75, 228 Tribble, 1999, AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease, Circulation, 99, 591, 10.1161/01.CIR.99.4.591 Stephens, 1996, Randomised controlled trial of vitamin E in patients with coronary disease, Lancet, 347, 781, 10.1016/S0140-6736(96)90866-1 Hodis, 1995, Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis, JAMA, 273, 1849, 10.1001/jama.1995.03520470057032 Rapola, 1997, Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction, Lancet, 349, 1715, 10.1016/S0140-6736(97)01234-8 Gaziano, 1999, Antioxidant vitamins and cardiovascular disease, Proc Assoc Am Physicians, 111, 2, 10.1046/j.1525-1381.1999.09229.x Agatston, 1990, Quantification of coronary artery calcium using ultrafast computed tomography, J Am Coll Cardiol, 15, 827, 10.1016/0735-1097(90)90282-T Callister, 1998, Coronary artery disease, Radiology, 208, 807, 10.1148/radiology.208.3.9722864 Rose, 1965, Chest Pain Questionnaire, Milibank Mem Fund, 43, 32, 10.2307/3348873 1999, Eur Heart J, 20, 725, 10.1053/euhj.1998.1350